cjc-1295/ipamorelin peptides CJC-1295 + Ipamorelin | GH Peptide Therapy CJC1295/Ipamorelin (No DAC) - Apollo

For Anti-Aging and Skin Quality Both peptides can produce modest effects on skin thickness, hair quality, and tissue recovery through IGF-1 elevation

The Case for Sermorelin: When the Gentler Approach Fits Despite being the oldest compound in the sermorelin vs CJC-1295 vs ipamorelin comparison, sermorelin retains clear research advantages in specific contexts

Sermorelin , known by its chemical name as GRF 1-29, is a synthetic analog of growth hormone-releasing hormone (GHRH)

Ipamorelin vs GHRP-2 and GHRP-6 GHRP Family Side-by-Side Feature Receptor Ipamorelin GHS-R1a GHRP-2 GHS-R1a GHRP-6 GHS-R1a Feature Half-life Ipamorelin ~2 hours GHRP-2 ~25-30 minutes GHRP-6 ~20-30 minutes Feature Dosing Ipamorelin 1-3x daily (SubQ) GHRP-2 2-3x daily (SubQ) GHRP-6 2-3x daily (SubQ) Feature Standard dose Ipamorelin 100-300 mcg GHRP-2 100-300 mcg GHRP-6 100-300 mcg Feature Cortisol effect Ipamorelin None at standard doses GHRP-2 Yes GHRP-6 Yes Feature Prolactin effect Ipamorelin None GHRP-2 Moderate GHRP-6 Minimal Feature Appetite effect Ipamorelin Mild GHRP-2 Moderate GHRP-6 Strong Feature FDA status Ipamorelin Not approved GHRP-2 Not approved GHRP-6 Not approved All three target the same receptor

IF For double staining, samples were incubated in 0.02 N HCl for 20 min following the first antibody signal amplification

CJC-1295 (No DAC) 5mg + Ipamorelin 5mg Research Grade Peptide Blend